Yahao Bu, Ph.D.
Affiliations: | 2007 | Roswell Park - Cellular and Molecular Biology | State University of New York, Buffalo, Buffalo, NY, United States |
Area:
Cell BiologyGoogle:
"Yahao Bu"Parents
Sign in to add mentor| Irwin H. Gelman | grad student | 2007 | SUNY Buffalo | |
| (Dissection of the SSeCKS metastasis suppressor gene promoters: Identification of v -Src responsive elements.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Cutler MJ, Belko KE, Bu Y, et al. (2019) Abstract 4717: Effective preclinical management of angiosarcoma with oral paclitaxel Cancer Research. 79: 4717-4717 |
| Smolinski MP, Bu Y, Clements J, et al. (2018) Discovery of Novel Dual Mechanism of Action Src Signaling and Tubulin Polymerization Inhibitors (KX2-391 and KX2-361). Journal of Medicinal Chemistry |
| Gao Z, Bu Y, Liu X, et al. (2016) TCDD promoted EMT of hFPECs via AhR, which involved the activation of EGFR/ERK signaling. Toxicology and Applied Pharmacology |
| Anbalagan M, Ali A, Jones RK, et al. (2012) Peptidomimetic Src/pretubulin inhibitor KX-01 alone and in combination with paclitaxel suppresses growth, metastasis in human ER/PR/HER2-negative tumor xenografts. Molecular Cancer Therapeutics. 11: 1936-47 |
| Fallah-Tafti A, Foroumadi A, Tiwari R, et al. (2011) Thiazolyl N-benzyl-substituted acetamide derivatives: synthesis, Src kinase inhibitory and anticancer activities. European Journal of Medicinal Chemistry. 46: 4853-8 |
| Bu Y, Gao L, Gelman IH. (2011) Role for transcription factor TFII-I in the suppression of SSeCKS/Gravin/Akap12 transcription by Src. International Journal of Cancer. Journal International Du Cancer. 128: 1836-42 |
| Su B, Bu Y, Engelberg D, et al. (2010) SSeCKS/Gravin/AKAP12 inhibits cancer cell invasiveness and chemotaxis by suppressing a protein kinase C- Raf/MEK/ERK pathway. The Journal of Biological Chemistry. 285: 4578-86 |
| Bu Y, Gao L, Hangauer D, et al. (2010) Abstract 2534: Suppression of prostate cancer growth by the Src signaling inhibitor, KXO1 (KX2-391) Cancer Research. 70: 2534-2534 |
| Bu Y, Smolinski M, Qu J, et al. (2010) Abstract 2487: Mechanism of action KX01 (KX2-391), a novel tubulin polymerization and Src signaling inhibitor proceeding to Phase II clinical trials Cancer Research. 70: 2487-2487 |
| Sachdev S, Bu Y, Gelman IH. (2009) Paxillin-Y118 phosphorylation contributes to the control of Src-induced anchorage-independent growth by FAK and adhesion. Bmc Cancer. 9: 12 |